| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/12/2004 | US20040154534 Fluid ejection cartridge and system for dispensing a bioactive substance |
| 08/12/2004 | US20040154317 Lyophilization method and apparatus for producing particles |
| 08/12/2004 | DE10304226A1 Nanoparticulate carrier for active ingredients, e.g. for pharmaceutical, cosmetic, agrochemical and food applications, comprises a colloidal dispersion with a hydrophobic dispersed phase in a thermotropic liquid crystal state |
| 08/12/2004 | DE10303527A1 Stable suspensions of carotenoids, retinoids and/or unsaturated fatty acids, useful as additives in food, feed, pharmaceutical or cosmetic preparations, containing insoluble ascorbate salt particles as antioxidant |
| 08/12/2004 | CA2573363A1 Liquid pharmaceutical formulations of palonosetron |
| 08/12/2004 | CA2573241A1 Liquid pharmaceutical formulations of palonosetron |
| 08/12/2004 | CA2573228A1 Liquid pharmaceutical formulations of palonosetron |
| 08/12/2004 | CA2573194A1 Liquid pharmaceutical formulations of palonosetron |
| 08/12/2004 | CA2549994A1 Otologic nanotechnology |
| 08/12/2004 | CA2515585A1 Enteric sustained-release fine particles for tamsulosin or its salt and manufacturing method thereof |
| 08/12/2004 | CA2514548A1 Suspension vehicle for coated drug particles |
| 08/12/2004 | CA2514474A1 Freeze-dried fibrin matrices and methods for preparation thereof |
| 08/12/2004 | CA2514392A1 Active drug delivery in the gastrointestinal tract |
| 08/12/2004 | CA2514109A1 Improved formulations for transmucosal vaginal delivery of bisphosphonates |
| 08/12/2004 | CA2514066A1 Sensitive proteasome sensor constructs and methods for their design and use |
| 08/12/2004 | CA2513884A1 Controlled release of highly soluble agents |
| 08/12/2004 | CA2513759A1 Ceramic based nanoparticles for entrapping therapeutic agents for photodynamic therapy and method of using same |
| 08/12/2004 | CA2513598A1 Use of the cathelicidin ll-37 and derivatives thereof for wound healing |
| 08/12/2004 | CA2512988A1 Dispersion of taste masked crystals or granules of active substances, chewable soft capsules filled with said dispersion, and process for preparing same |
| 08/12/2004 | CA2512738A1 Method for producing an oral pharmaceutical form with immediate disintegration and active ingredient release |
| 08/12/2004 | CA2512559A1 A rapid-acting pharmaceutical composition |
| 08/12/2004 | CA2509807A1 Powder pharmaceutical compositions |
| 08/12/2004 | CA2493899A1 Controlled release modifying complex and pharmaceutical compositions thereof |
| 08/11/2004 | EP1444978A1 Amino acid-containing tablets quickly disintegrating in the oral cavity and process for producing the same |
| 08/11/2004 | EP1444977A1 Transdermal therapeutic delivery system with a butenolide |
| 08/11/2004 | EP1444976A1 Buccal, polar and non-polar spray or capsule |
| 08/11/2004 | EP1444263A2 Method for improving stability of a bone-connecting implant |
| 08/11/2004 | EP1444248A2 Novel anti-inflammatory androstane derivatives - 17-carboxy-lactone substituted steroids with an aryl-carboxylic ester in position 17.alpha |
| 08/11/2004 | EP1444247A2 Novel tibolone formulations |
| 08/11/2004 | EP1444033A1 Method for the preparation of purified microparticles |
| 08/11/2004 | EP1443990A1 Impedance sensor |
| 08/11/2004 | EP1443982A2 Porous polymeric prostheses and methods for making same |
| 08/11/2004 | EP1443968A1 Edible film |
| 08/11/2004 | EP1443964A1 Photodynamic therapy for the treatment of hair loss |
| 08/11/2004 | EP1443948A1 Process for the preparation of anthocyanin-containing products |
| 08/11/2004 | EP1443940A1 Pharmaceutical composition based on micronized progesterone, preparation method and uses thereof |
| 08/11/2004 | EP1443939A1 Compositions for treatment of postmenopausal female sexual dysfunction |
| 08/11/2004 | EP1443935A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 08/11/2004 | EP1443932A1 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 08/11/2004 | EP1443921A1 PRODUCTION OF PURE STEREOISOMERS OF TRICYCLO 5.2.1.0 sp 2.6 /sp -DEC-9-YL XANTHOGENATE AND MEDICAMENTS THEREFROM |
| 08/11/2004 | EP1443917A1 Tamsulosin tablets |
| 08/11/2004 | EP1443915A1 Pharmaceutical and cosmetic compositions containing oxy group-bearing aromatic aldehydes |
| 08/11/2004 | EP1443912A2 Compositions having a combination of immediate release and controlled release characteristics |
| 08/11/2004 | EP1443911A1 Process for preparing quick dissolving, high loading ribavirin compositions |
| 08/11/2004 | EP1443910A1 Controlled release compositions for macrolide antimicrobial agents |
| 08/11/2004 | EP1443909A1 Process for preparing dry extracts |
| 08/11/2004 | EP1443908A2 Nonostructured compositions |
| 08/11/2004 | EP1443907A1 Biocompatible polymer blends and uses thereof |
| 08/11/2004 | EP1443906A1 Method for the formation of ibuprofen crystals |
| 08/11/2004 | EP1443905A2 Compositions for oral gene therapy and methods of using same |
| 08/11/2004 | EP1443904A2 Orally administered pharmaceutical preparation comprising liposomically encapsulated paclitaxel |
| 08/11/2004 | EP1443903A2 Proliposomal drug delivery system |
| 08/11/2004 | EP1443902A2 Method for producing stable solutions of phenolic substances and resulting solutions |
| 08/11/2004 | EP1443901A2 Soluble drug extended release system |
| 08/11/2004 | EP1443900A2 Lipid carrier compositions with enhanced blood stability |
| 08/11/2004 | EP1443899A2 Bowel cleansing agent |
| 08/11/2004 | EP1443897A1 Carotenoid composition and method for protecting skin |
| 08/11/2004 | EP1399531A4 Methods and formulations for enhancing the dissolution of a solid material in liquid |
| 08/11/2004 | EP1365764A4 Oral pharmaceutical composition of cefpodoxime proxetil |
| 08/11/2004 | EP1345614B1 Improved and stable extract from hypericum perforatum l. , method for the production thereof and its use as a topical medicament |
| 08/11/2004 | EP1339397B1 Absorbing agents and cover layer which is impermeable to active substances and which contains channel-formers or removable protective layer of a transdermal therapeutic system |
| 08/11/2004 | EP1324782B1 Stabilized ophthalmic hydrogen peroxide solutions |
| 08/11/2004 | EP1305109B1 Production of polyelectrolyte capsules by surface precipitation |
| 08/11/2004 | EP1272044B1 Protein stabilised emulsions |
| 08/11/2004 | EP1233750B1 Novel positive latex and use in cosmetics |
| 08/11/2004 | EP1143954B1 Use of nicotinic acid derivatives for the treatment of dna damage in skin cells |
| 08/11/2004 | EP1086524A4 Chuck apparatus for clamping a planar substrate in an electrostatic coating method |
| 08/11/2004 | EP1059939B1 Apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
| 08/11/2004 | EP1042007B1 Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions |
| 08/11/2004 | EP1028991B1 Strictly alternating poly(alkylene oxide ether) copolymers |
| 08/11/2004 | EP1028774B1 Biodegradable, anionic polymers derived from the amino acid l-tyrosine |
| 08/11/2004 | EP0996508B1 Film coatings and film coating compositions based on dextrin |
| 08/11/2004 | EP0984772B1 Composition comprising a liquid absorbed on a support based on precipitate silica |
| 08/11/2004 | EP0954288B1 Solid solution of an antifungal agent with enhanced bioavailability |
| 08/11/2004 | EP0910576B1 Fusogenic liposomes |
| 08/11/2004 | EP0852491B1 Use of heparinases to decrease inflammatory responses |
| 08/11/2004 | CN1520437A Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug |
| 08/11/2004 | CN1520435A Lipid-polymer-conjugates compsns. |
| 08/11/2004 | CN1520403A Novel polymorph v of torasemide |
| 08/11/2004 | CN1520373A Packaging system for transdermal drug delivery systems |
| 08/11/2004 | CN1520325A Antitumoral formulations of thioxanthenone |
| 08/11/2004 | CN1520313A Compsns. for promoting healing of bone racture |
| 08/11/2004 | CN1520311A Cancer vaccine contg. cancer antigen based on tumor suppressor gene WT1 product and cationic liposomes |
| 08/11/2004 | CN1520309A Methods and compsns. for treating oral and eosophagal lesions |
| 08/11/2004 | CN1520305A Compsns. for preparing external carbon dioxide agents |
| 08/11/2004 | CN1520297A Sustained release drug delivery system contg. codrugs |
| 08/11/2004 | CN1520294A Crystalline anticholinergic, method for its prodn., and use thereof in prdon of drug |
| 08/11/2004 | CN1520292A Medicinal compsns. |
| 08/11/2004 | CN1520291A Fumaric acid derivatives as NF-Kappab inhibitors |
| 08/11/2004 | CN1520287A Method of tablet enrobing |
| 08/11/2004 | CN1520286A Gastric retention controlled drug delivery system |
| 08/11/2004 | CN1520285A Tablet comprising cetirizine and pseudoephedrine |
| 08/11/2004 | CN1520283A Control of compactability through crystallization |
| 08/11/2004 | CN1520261A Polybutene contg chewing gun and confection |
| 08/11/2004 | CN1519325A Shuttle plasmid of adenovirus and its constructing method |
| 08/11/2004 | CN1519022A Gelling agent of stimulating factor of macrophage colony of recombined human granular leudocytes and preparation method |
| 08/11/2004 | CN1519020A Combined medication of reduction typed glutathione and selenium compound |
| 08/11/2004 | CN1519019A Medicine for treating burns and scalds and preparation method |
| 08/11/2004 | CN1519017A Combination of Chinese traditional medicine for treating menorrhagia as well as pharmaceutics and preparation method |
| 08/11/2004 | CN1519014A Multifunctional ointment for promoting blood flow and composedness as well as preparation method |